Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: Deleterious BRCA2 mutations in 17%

Cancer Research

Volumn 62, Issue 13, 2002, Pages 3789-3793

  Murphy, Kathleen M ^a   Brune, Kieran A ^a   Griffin, Constance ^a   Sollenberger, Jennifer E ^a   Petersen, Gloria M ^a   Bansal, Ravi ^a   Hruban, Ralph H ^a   Kern, Scott E ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DNA SEQUENCE; FAMILIAL CANCER; FAMILY HISTORY; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; PANCREAS CANCER; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

ACTIVIN RECEPTORS, TYPE I; ADULT; AGED; AGED, 80 AND OVER; DNA-BINDING PROTEINS; FEMALE; GENES, BRCA2; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PEDIGREE; PROTEINS; SMAD4 PROTEIN; TRANS-ACTIVATORS;

EID: 0036644884     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. The national cancer data base report on pancreatic cancer
2. Periampullary adenocarcinoma: Analysis of 5-year survivors
3. Pancreatic carcinoma
4. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer
5. Familial pancreatic cancer: A review
6. Genetics of pancreatic cancer. From genes to families
7. Pancreatic carcinoma in brothers
8. Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature
9. Cancer of the pancreas in two brothers and one sister
10. Familial pancreatic cancer: Clinicopathologic study of 18 nuclear families
11. Adenocarcinoma of the pancreas in four siblings
12. Pancreatic cancer in father and son
13. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer
14. Tobacco, alcohol, and coffee and cancer of the pancreas. A population-based, case-control study in Quebec, Canada
15. Family history and the risk of liver, gallbladder, and pancreatic cancer
16. Predictors of pancreatic cancer mortality among a large cohort of United States adults
17. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer
18. Cancer risks in BRCA2 mutation carriers
19. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
20. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas
21. DPC4 gene in various tumor types
22. ACVRIB (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma
23. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor
24. Familial pancreatic cancer
25. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene
26. Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma
27. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients
28. BRCA1, BRCA2 and their possible function in DNA damage response
29. A polymorphic stop codon in BRCA2
30. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms
31. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2
32. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families
33. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes
34. BRCA2 in American families with four or more cases of breast or ovarian cancer: Recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2
35. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals
36. Conversion of diploidy to haploidy
37. Inherited predisposition to pancreatic adenocarcinoma: Role of family history and germ-line p16. BRCA1, and BRCA2 mutations
38. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: Evidence and implications
39. A BRCA2 germ-line mutation in familial pancreatic carcinoma